- Johnson & Johnson offers up to $5.5bn to settle lawsuits alleging its talc-based baby powder causes ovarian cancer.
- The settlement aims to resolve about 76,000 cases, representing most remaining talc-related claims, pending acceptance by legal firms representing 95% of ovarian cancer claimants.
- J&J denies allegations, claims studies show talc is safe, and has transitioned to cornstarch-based baby powder globally after ending talc sales in the US in 2020.